The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: Prospective validation of the definition of improvement
Authors:
- Nicolino RupertoNRNicolino Ruperto
- Angelo RavelliARAngelo Ravelli
- Elisabetta CortisECElisabetta Cortis
Open Access
- 31 May 2006
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 55 (3) , 355-363
Abstract
Objective: To use the Pediatric Rheumatology International Trials Organization (PRINTO) core set of outcome measures to develop a validated definition of improvement for the evaluation of response to therapy in juvenile systemic lupus erythematosus (SLE).Methods: Thirty‐seven experienced pediatric rheumatologists from 27 countries, each of whom had specific experience in the assessment of juvenile SLE patients, achieved consensus on 128 patient profiles as being clinically improved or not improved. Using the physicians' consensus ratings as the gold standard measure, the chi‐square, sensitivity, specificity, false‐positive and false‐negative rates, area under the receiver operating characteristic curve, and kappa level of agreement for 597 candidate definitions of improvement were calculated. Only definitions with a kappa value greater than 0.7 were retained. The top definitions were selected based on the product of the content validity score multiplied by its kappa statistic.Results: The definition of improvement with the highest final score was at least 50% improvement from baseline in any 2 of the 5 core set measures, with no more than 1 of the remaining worsening by more than 30%.Conclusion: PRINTO proposes a valid and reproducible definition of improvement that reflects well the consensus rating of experienced clinicians and that incorporates clinically meaningful change in core set measures in a composite end point for the evaluation of global response to therapy in patients with juvenile SLE. The definition is now proposed for use in juvenile SLE clinical trials and may help physicians to decide whether a child with SLE responded adequately to therapy.Keywords
This publication has 23 references indexed in Scilit:
- The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: Prospective validation of the disease activity core setArthritis & Rheumatism, 2005
- Criteria for steroid‐sparing ability of interventions in systemic lupus erythematosus: Report of a consensus meetingArthritis & Rheumatism, 2004
- Life of the mind: The interface of psychopharmaceuticals, domestic economies, and social abandonmentAmerican Ethnologist, 2004
- Biomarkers, surrogate markers, and design of clinical trials of new therapies for systemic lupus erythematosusArthritis & Rheumatism, 2004
- International consensus on preliminary definitions of improvement in adult and juvenile myositisArthritis & Rheumatism, 2004
- Preliminary definition of improvement in juvenile arthritisArthritis & Rheumatism, 1997
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992
- Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosusArthritis & Rheumatism, 1989
- Basic principles of ROC analysisSeminars in Nuclear Medicine, 1978